Early results from an Ebola trial using Avigan (favipiravir), the experimental drug, showed that it was somewhat effective at saving lives if given early in the illness, but not later, as reported on Monday. The antiviral treatment is being developed by the Japanese company Toyama Chemical, and has been shown safe and effective against some other viruses including influenza, West Nile and yellow fever. An ongoing clinical trial in Guinea is testing the ...
Read More
You have just read an article categorized health
titled Early Results from Ebola Drug Trial Shows Limited Promise.
Written by:
editor -
Tuesday, February 24, 2015
There are currently no comments for "Early Results from Ebola Drug Trial Shows Limited Promise"
Post a Comment